Usefulness of Brain Natriuretic Peptide Levels in the Clinical Evaluation of Patients With Hypertrophic Cardiomyopathy

Josepha Binder, Steve R. Ommen, Horng Haur Chen, Michael John Ackerman, A. Jamil Tajik, Allan S Jaffe

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Hypertrophic cardiomyopathy (HC) is associated frequently with heart failure symptoms and diastolic dysfunction. Although the influence of brain natriuretic peptide (BNP) levels in the management of patients with systolic dysfunction is evolving, there are few data on the role of BNP in the management of patients with HC. BNP was compared with clinical and echocardiographic variables, including measures of diastolic filling, in 217 patients with HC. BNP values were correlated with New York Heart Association classification, echocardiographic estimates of diastolic filling pressure, and right ventricular systolic pressure even after adjusting for age, gender, renal function, and body habitus. However, the overlap of the BNP levels in these respective categories was notable. BNP values did not correlate with objective measures of exercise capacity, and serial BNP values did not track changes in clinical status. In conclusion, BNP levels in patients with HC are associated with similar subjective and objective measures as have been observed in patients with left ventricular systolic dysfunction, but these correlations are relatively weak and do not allow the precise characterization of clinical status.

Original languageEnglish (US)
Pages (from-to)712-714
Number of pages3
JournalAmerican Journal of Cardiology
Volume100
Issue number4
DOIs
StatePublished - Aug 15 2007

Fingerprint

Brain Natriuretic Peptide
Hypertrophic Cardiomyopathy
Diastolic Heart Failure
Blood Pressure
Left Ventricular Dysfunction
Ventricular Pressure
Exercise
Kidney

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of Brain Natriuretic Peptide Levels in the Clinical Evaluation of Patients With Hypertrophic Cardiomyopathy. / Binder, Josepha; Ommen, Steve R.; Chen, Horng Haur; Ackerman, Michael John; Tajik, A. Jamil; Jaffe, Allan S.

In: American Journal of Cardiology, Vol. 100, No. 4, 15.08.2007, p. 712-714.

Research output: Contribution to journalArticle

@article{4dd3632df6544810a70261f5d782c72d,
title = "Usefulness of Brain Natriuretic Peptide Levels in the Clinical Evaluation of Patients With Hypertrophic Cardiomyopathy",
abstract = "Hypertrophic cardiomyopathy (HC) is associated frequently with heart failure symptoms and diastolic dysfunction. Although the influence of brain natriuretic peptide (BNP) levels in the management of patients with systolic dysfunction is evolving, there are few data on the role of BNP in the management of patients with HC. BNP was compared with clinical and echocardiographic variables, including measures of diastolic filling, in 217 patients with HC. BNP values were correlated with New York Heart Association classification, echocardiographic estimates of diastolic filling pressure, and right ventricular systolic pressure even after adjusting for age, gender, renal function, and body habitus. However, the overlap of the BNP levels in these respective categories was notable. BNP values did not correlate with objective measures of exercise capacity, and serial BNP values did not track changes in clinical status. In conclusion, BNP levels in patients with HC are associated with similar subjective and objective measures as have been observed in patients with left ventricular systolic dysfunction, but these correlations are relatively weak and do not allow the precise characterization of clinical status.",
author = "Josepha Binder and Ommen, {Steve R.} and Chen, {Horng Haur} and Ackerman, {Michael John} and Tajik, {A. Jamil} and Jaffe, {Allan S}",
year = "2007",
month = "8",
day = "15",
doi = "10.1016/j.amjcard.2007.03.089",
language = "English (US)",
volume = "100",
pages = "712--714",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Usefulness of Brain Natriuretic Peptide Levels in the Clinical Evaluation of Patients With Hypertrophic Cardiomyopathy

AU - Binder, Josepha

AU - Ommen, Steve R.

AU - Chen, Horng Haur

AU - Ackerman, Michael John

AU - Tajik, A. Jamil

AU - Jaffe, Allan S

PY - 2007/8/15

Y1 - 2007/8/15

N2 - Hypertrophic cardiomyopathy (HC) is associated frequently with heart failure symptoms and diastolic dysfunction. Although the influence of brain natriuretic peptide (BNP) levels in the management of patients with systolic dysfunction is evolving, there are few data on the role of BNP in the management of patients with HC. BNP was compared with clinical and echocardiographic variables, including measures of diastolic filling, in 217 patients with HC. BNP values were correlated with New York Heart Association classification, echocardiographic estimates of diastolic filling pressure, and right ventricular systolic pressure even after adjusting for age, gender, renal function, and body habitus. However, the overlap of the BNP levels in these respective categories was notable. BNP values did not correlate with objective measures of exercise capacity, and serial BNP values did not track changes in clinical status. In conclusion, BNP levels in patients with HC are associated with similar subjective and objective measures as have been observed in patients with left ventricular systolic dysfunction, but these correlations are relatively weak and do not allow the precise characterization of clinical status.

AB - Hypertrophic cardiomyopathy (HC) is associated frequently with heart failure symptoms and diastolic dysfunction. Although the influence of brain natriuretic peptide (BNP) levels in the management of patients with systolic dysfunction is evolving, there are few data on the role of BNP in the management of patients with HC. BNP was compared with clinical and echocardiographic variables, including measures of diastolic filling, in 217 patients with HC. BNP values were correlated with New York Heart Association classification, echocardiographic estimates of diastolic filling pressure, and right ventricular systolic pressure even after adjusting for age, gender, renal function, and body habitus. However, the overlap of the BNP levels in these respective categories was notable. BNP values did not correlate with objective measures of exercise capacity, and serial BNP values did not track changes in clinical status. In conclusion, BNP levels in patients with HC are associated with similar subjective and objective measures as have been observed in patients with left ventricular systolic dysfunction, but these correlations are relatively weak and do not allow the precise characterization of clinical status.

UR - http://www.scopus.com/inward/record.url?scp=34547678493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547678493&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2007.03.089

DO - 10.1016/j.amjcard.2007.03.089

M3 - Article

C2 - 17697834

AN - SCOPUS:34547678493

VL - 100

SP - 712

EP - 714

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -